We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$598M
AUM Growth
-$18.6M
Cap. Flow
-$8.96M
Cap. Flow %
-1.5%
Top 10 Hldgs %
41.22%
Holding
83
New
1
Increased
18
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
PODD icon
Insulet
PODD
+$706K
2
PAYX icon
Paychex
PAYX
+$433K
3
ROST icon
Ross Stores
ROST
+$180K
4
VZ icon
Verizon
VZ
+$134K
5
MON
Monsanto Co
MON
+$106K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.93M
2
TIF
Tiffany & Co.
TIF
+$836K
3
KOF icon
Coca-Cola Femsa
KOF
+$778K
4
SYT
Syngenta Ag
SYT
+$693K
5
CGNX icon
Cognex
CGNX
+$397K

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 15.99%
3 Industrials 11.48%
4 Consumer Staples 10.15%
5 Energy 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.5B
$37.1M 6.21%
112,289
-8,881
-7% -$2.93M
TIF
2
DELISTED
Tiffany & Co.
TIF
$34M 5.69%
353,336
-8,388
-2% -$836K
SSYS icon
3
Stratasys
SSYS
$701M
$29.1M 4.86%
240,577
-2,243
-0.9% -$253K
JNJ icon
4
Johnson & Johnson
JNJ
$599B
$24.5M 4.1%
229,886
-3,796
-2% -$394K
BF.B icon
5
Brown-Forman Class B
BF.B
$12.1B
$23.5M 3.93%
814,875
-12,238
-1% -$360K
CGNX icon
6
Cognex
CGNX
$10.5B
$20.9M 3.49%
1,036,780
-19,200
-2% -$397K
SLB icon
7
SLB Ltd
SLB
$69.4B
$19.7M 3.29%
193,622
-2,215
-1% -$241K
NVO
8
Novo Nordisk
NVO
$219B
$19.4M 3.24%
814,140
-10,300
-1% -$237K
DHR icon
9
Danaher
DHR
$142B
$19.4M 3.23%
378,917
-2,335
-0.6% -$120K
GWW icon
10
W.W. Grainger
GWW
$64.7B
$19.1M 3.19%
75,940
-335
-0.4% -$82.2K
ADI icon
11
Analog Devices
ADI
$181B
$16.6M 2.78%
335,734
+1,270
+0.4% +$65.1K
HON icon
12
Honeywell
HON
$71.7B
$16.2M 2.71%
193,900
-1,594
-0.8% -$135K
RTN
13
DELISTED
Raytheon Company
RTN
$15.3M 2.56%
150,752
+800
+0.5% +$76.7K
NEOG icon
14
Neogen
NEOG
$2.18B
$14.2M 2.38%
961,859
-7,413
-0.8% -$117K
CTXS
15
DELISTED
Citrix Systems Inc
CTXS
$13.9M 2.33%
245,557
-3,658
-1% -$199K
AMGN icon
16
Amgen
AMGN
$197B
$13.7M 2.29%
97,727
-2,215
-2% -$289K
SYT
17
DELISTED
Syngenta Ag
SYT
$13.6M 2.28%
215,192
-9,791
-4% -$693K
HSIC icon
18
Henry Schein
HSIC
$9.82B
$12.7M 2.13%
278,983
-6,630
-2% -$307K
KOF icon
19
Coca-Cola Femsa
KOF
$21.8B
$12.6M 2.1%
125,010
-7,116
-5% -$778K
TRMB icon
20
Trimble
TRMB
$12.4B
$11.7M 1.95%
382,915
+2,664
+0.7% +$86.6K
IDXX icon
21
Idexx Laboratories
IDXX
$44.5B
$11M 1.84%
187,060
-370
-0.2% -$23.4K
DXCM icon
22
DexCom
DXCM
$29.2B
$11M 1.84%
1,098,900
-13,400
-1% -$137K
PODD icon
23
Insulet
PODD
$11.6B
$9.98M 1.67%
270,825
+19,350
+8% +$706K
GE icon
24
GE Aerospace
GE
$354B
$9.97M 1.67%
81,182
-2,953
-4% -$368K
WSM icon
25
Williams-Sonoma
WSM
$26.3B
$9.94M 1.66%
298,560
-500
-0.2% -$17.3K

Similar funds

Tirschwell & Loewy's Q3 2014 Portfolio in Review

As of Q3 2014, Tirschwell & Loewy held 83 positions worth $598M, down 3% from $617M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.4%. Tirschwell & Loewy opened 1 new position and exited 1, leaving the 83-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q3 2014 buy was Paychex: 10,300 shares worth $455K.
  • Tirschwell & Loewy added most to Insulet in Q3 2014, an estimated $706K increase.
  • Tirschwell & Loewy's biggest Q3 2014 reduction was Biogen, cutting an estimated $2.93M.
  • Tirschwell & Loewy fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $200K.
  • Tirschwell & Loewy's ten largest holdings make up 41% of its $598M portfolio in Q3 2014.
  • Tirschwell & Loewy opened 1 new position and closed 1 in Q3 2014.
  • Tirschwell & Loewy's portfolio value fell 3% quarter-over-quarter to $598M.

Based on Tirschwell & Loewy's 13F filing for Q3 2014, filed 5 Nov 2014.